T. Rowe Price Associates’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $16.6M | Buy |
|
|||||
|
2022
Q2 | $7.68M | Sell |
|
|||||
|
2022
Q1 | $9.17M | Sell |
|
|||||
|
2021
Q4 | $13.4M | Sell |
|
|||||
|
2021
Q3 | $6.44M | Sell |
|
|||||
|
2021
Q2 | $5.96M | Buy |
|
|||||
|
2021
Q1 | $22.4M | Buy |
|
|||||
|
2020
Q4 | $25M | Buy |
|
|||||
|
2020
Q3 | $15.4M | Sell |
|
|||||
|
2020
Q2 | $36.4M | Buy |
|
|||||
|
2020
Q1 | $6.75M | Buy |
|
|||||
|
2019
Q4 | $3.62M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $6.26M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $3.6M | Sell |
|
|||||
|
2013
Q2 | $9.49M | Buy |
|